IDELALISIB

7040 reported adverse events

Drug classes: Kinase Inhibitor [EPC]

These side effects are most commonly reported by patients taking IDELALISIB:

# Side effect Count
0 DISEASE PROGRESSION 1225
1 DEATH 802
2 DIARRHOEA 771
3 OFF LABEL USE 573
4 PNEUMONIA 437
5 PYREXIA 375
6 DRUG INEFFECTIVE 318
7 FATIGUE 301
8 DEHYDRATION 244
9 NEUTROPENIA 224
See all common reactions for IDELALISIB

IDELALISIB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CHRONIC LYMPHOCYTIC LEUKAEMIA REFRACTORY 15 0.1596
1 SCOPULARIOPSIS INFECTION 7 0.1556
2 SPLEEN ATROPHY 9 0.1525
3 LYMPHADENITIS VIRAL 6 0.1500
4 B-CELL LYMPHOMA REFRACTORY 13 0.1461
5 EPILEPSIA PARTIALIS CONTINUA 6 0.1429
6 MIXED DEMENTIA 6 0.0938
7 CHRONIC LYMPHOCYTIC LEUKAEMIA RECURRENT 54 0.0775
8 LEUKAEMIC INFILTRATION 10 0.0714
9 RETICULOCYTOPENIA 10 0.0685
See all enriched reactions for IDELALISIB